← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Everglades Biopharma, Llc
Houston, TX
$2,670,111
Total funding
4
Grants
Funding over time
peak $981.9K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,670,111 · 4
By mechanism
R44$1,963,529 · 1
R43$481,582 · 2
R41$225,000 · 1
Investigators at Everglades Biopharma, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Developing a novel therapy for diabetic retinopathy$981,868
R44 · FY2024 · EY
Developing a novel therapy for diabetic retinopathy$981,661
R44 · FY2025 · EY
A new drug entity for combination therapy of diabetic retinopathy$256,582
R43 · FY2021 · EY
Developing a novel therapy for diabetic retinopathy$225,000
R41 · FY2017 · EY
Anti-angiogenic gene therapy of ocular vascular diseases$225,000
R43 · FY2020 · EY